A small Czech company managed to develop a unique bioactive compo with a wide range of applications in cosmetic and pharmaceutical industries. The company is looking for prospects that wish to implement the compo into their current or new line of products. The compo is available as a concentrate.

A small Czech company managed to develop a unique bioactive compo with a wide range of applications in cosmetic and pharmaceutical industries.

Today, many people face multiple cosmetic defects such as wrinkles, cellulitis, stretch marks, pigment stains, scars, hairs falls, bloating, haematoma, and also diseases such as psoriasis, atopic eczema, herpes, HPV (Human Papillomavirus) infection, burns, haemorrhoids, varicose ulcers, etc., which are difficult to shake off. Multiple conventional treatments are unsuccessful in both defects and diseases elimination, and provide only a temporary solution.

The bioactive compo developed by the Czech company has shown exceptional medical results - it promotes the immune system, regenerates and heals. In certain cases, the compo has fully substituted corticoids therapy; it has had a complex effect on treatment of HPV infections and other viral ones. It regenerates body tissue, promotes blood circulation, and removes necrotic parts. In addition, an impact on commonly resistant Staphylococcus aureus has been proved, too, and it also well substituted surgical intervention commonly used to remove haemorrhoids, as well.

However, the bioactive compo is interesting in the cosmetics industry, too, as it proved to be very effective in combating wrinkles, cellulitis, stretch marks, pigment stains, scars, hairs falls, etc. Currently, the company applies the compo in cosmetic products.

A unique feature of the bioactive compo is grounded in a patented technology enabling to stabilise effective substances that, in normal conditions, react mutually and liquidate themselves within 24 hours. The substances are inactive to most cosmetic carriers, and are activated just when they get in contact with live tissue. When applied, the compo is smoothly absorbed by both broken and unbroken skin, and it decomposes necrotic parts of the skin without damaging healthy cells (it actually nourishes them).

During a few occasional tests the product proved its high effectiveness while curing psoriasis, atopic eczema, herpes, HPV infection, burns, haemorrhoids, varicose ulcers, haematoma, and other diseases. Results of the occasional tests are available to serious prospects.

Last but not least, it is important to point out that the compo’s efficiency is most probably based on the properties of the Lumbricus Californicus species. In the past, it has been already confirmed by some independent studies that the cited species contain very high levels of concentration of mono-peptides, di-peptides, tri-peptides and polypeptides. The cited peptides are recognised as antimicrobial peptides - killers of bacteria, moulds and parasites. Some of the peptides are able to successfully attack tumour cells; others successfully attack viruses (not only those causing e.g. herpes). According to the scientists some of the peptides, derived from the species, are probably able to tackle even HIV virus, causing AIDS disease. Another beneficial aspect of the cited peptides: much higher safety when compared with chemically manufactured substances, because the peptides are almost free of side effects while they remain resistant to bacteria and viruses.

Based on results of studies the inventors are confident that all curing effects of the peptides have not been revealed yet. Today, it is just evident that the peptides will play important role in anti-tumour treatments and in combating infectious diseases. Innovative Aspects: - Noticeably combats various cosmetic defects

- Effective tool against diseases such as psoriasis, herpes, HPV infections, etc.

- Relatively long-term storage capability of the concentrate based on a unique stabilisation process

• Rozvojova 135,
• CZ - 165 02
• Tel.: +420 234 006 100
• Tel.: +420 234 006 139
• Fax.: +420 2 209 22 698
• lorenz@tc.cas.cz